GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Enterprise Value

Cathay Biotech (SHSE:688065) Enterprise Value : ¥27,427 Mil (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cathay Biotech's Enterprise Value is ¥27,427 Mil. Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥529 Mil. Therefore, Cathay Biotech's EV-to-EBIT ratio for today is 51.81.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cathay Biotech's Enterprise Value is ¥27,427 Mil. Cathay Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥529 Mil. Therefore, Cathay Biotech's EV-to-EBITDA ratio for today is 51.81.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cathay Biotech's Enterprise Value is ¥27,427 Mil. Cathay Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,293 Mil. Therefore, Cathay Biotech's EV-to-Revenue ratio for today is 11.96.


Cathay Biotech Enterprise Value Historical Data

The historical data trend for Cathay Biotech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Enterprise Value Chart

Cathay Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial - 29,498.59 71,923.39 34,670.64 32,068.32

Cathay Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35,425.59 35,724.23 32,200.82 32,068.32 26,055.59

Competitive Comparison of Cathay Biotech's Enterprise Value

For the Chemicals subindustry, Cathay Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cathay Biotech's Enterprise Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cathay Biotech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cathay Biotech's Enterprise Value falls into.



Cathay Biotech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cathay Biotech's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Cathay Biotech's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech  (SHSE:688065) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cathay Biotech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=27426.982/529.351
=51.81

Cathay Biotech's current Enterprise Value is ¥27,427 Mil.
Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥529 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cathay Biotech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=27426.982/529.351
=51.81

Cathay Biotech's current Enterprise Value is ¥27,427 Mil.
Cathay Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥529 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cathay Biotech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=27426.982/2293.251
=11.96

Cathay Biotech's current Enterprise Value is ¥27,427 Mil.
Cathay Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,293 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cathay Biotech (SHSE:688065) Business Description

Traded in Other Exchanges
N/A
Address
1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines